Intellectual Property India Publishes Patent Application for Methods Of Making And Using Ipsc-Derived Mural Progenitor Cells Via Activation Of Nkx3.1

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617060458 A) filed by The Children'S Medical Center Corporation on May 12, 2026, for Methods Of Making And Using Ipsc-Derived Mural Progenitor Cells Via Activation Of Nkx3.1.

Inventors include Melero-Martin, Juan M.; Lee, Umji; and Wang, Kai.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: Described herein, inter alia, are compositions comprising and methods of making and using iPSC-derived mural progenitor cells (iMPCs) generated using NK3 Homeobox 1 (NKX3.1; a mural cell fate-determining transcription factor). Also described herein, inter alia, are methods maturing the iMPCs into functiona...